Metabolic syndrome, also known as insulin resistance syndrome or syndrome X, happens when you have a group of health conditions that put you at a greater risk of developing heart disease ...
REL-P11 is a proprietary, low-dose, modified-release psilocybin formulation Single-Ascending Dosing (SAD) study to evaluate safety and pharmacokinetics in obese and normal weight subjects With ...